Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes
International Journal of Molecular Sciences · 03.04.2026 · 27 (7) · 3270
DOI: 10.3390/ijms27073270 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.04.2026. Verfasst von Lan Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany. Hauptthemen laut MEDLINE: Biomarkers, Metabolomics, Multiple System Atrophy, Supranuclear Palsy, Progressive. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karlheinz-Hartmann-Stiftung, Hilde-Ulrichs-Foundation, Frankfurt am Main, Germany, MHH plus Foundation.
Abstract (Originalsprache)
Diagnosis of atypical parkinsonian syndromes (APS), including progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), rely on clinical criteria that often result in misclassification or delayed confirmation. Cerebrospinal fluid (CSF) metabolomics offers the potential to identify disease-specific biochemical “fingerprints”. The aim of the study is to identify CSF metabolomic biomarkers that distinguish PSP and MSA from each other and from non-neurodegenerative controls. Targeted mass spectrometry-based metabolomics was performed on CSF samples from 30 patients with MSA, 41 with PSP, and 30 age- and sex-matched non-neurodegenerative controls. Global metabolomic profiles showed no clear group separation. Both PSP and MSA showed elevated gut-derived metabolites p-cresyl sulfate and deoxycholic acid versus controls. In PSP, decreased cortisone and increased hexosylceramide d18:1/24:1 were observed, whereas in MSA, dihydroxyphenylalanine was elevated alongside homoarginine and creatinine. In the direct comparison of APS, levels of α-aminoadipic acid were increased in PSP compared to MSA. Pathway analysis highlighted disrupted glycerophospholipid metabolism in both APS disorders. Distinct metabolite panels mainly combining membrane-associated lipids, gut-derived and neurotransmitter-related metabolites demonstrated high diagnostic accuracy for distinguishing PSP and MSA from control groups (AUC = 0.95 for PSP and AUC = 0.98 for MSA), while a separate panel showed moderate performance in differentiating PSP from MSA (AUC = 0.85). Distinct but partially overlapping CSF metabolomic profiles characterize PSP and MSA. These metabolomic fingerprints highlight gut–brain axis involvement, alterations in cell membrane-related lipid metabolism, and disease-specific changes in neurotransmitter-related metabolites. Further, a panel of these metabolites showed strong potential as diagnostic biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.
- Systems Neuroscience Hannover (ZSN), 30625 Hannover, Germany.
- Department of Bio- and Environmental Analytics, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), 30625 Hannover, Germany.
ORCID-Profile: Olivia Rudtke, Matthias Höllerhage, Sven Schuchardt, Martin Klietz
Förderung
- Karlheinz-Hartmann-Stiftung
- Hilde-Ulrichs-Foundation, Frankfurt am Main, Germany
- MHH plus Foundation
Zitieren
APA
Ye, L., Wegner, F., Smandzich, N. J., Rudtke, O., Efe, G. D., Höllerhage, M., Schneidereit, I. V., Greten, S., Schuchardt, S., & Klietz, M. (2026). Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes. International Journal of Molecular Sciences, 27(7), 3270. https://doi.org/10.3390/ijms27073270
Vancouver
Ye L, Wegner F, Smandzich NJ, Rudtke O, Efe GD, Höllerhage M, et al. Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes. International Journal of Molecular Sciences. 2026;27(7):3270. doi:10.3390/ijms27073270
BibTeX
@article{Ye2026,
author = {Ye, Lan and Wegner, Florian and Smandzich, Nadine J and Rudtke, Olivia and Efe, Gül Deniz and Höllerhage, Matthias and Schneidereit, Ishana Viktoria and Greten, Stephan and Schuchardt, Sven and Klietz, Martin},
title = {Metabolomic Cerebrospinal Fluid Biomarkers for the Diagnosis of Atypical Parkinsonian Syndromes},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3270},
doi = {10.3390/ijms27073270}
}
EUVIMED